Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
-
Published:2023-02
Issue:3
Volume:93
Page:215-223
-
ISSN:0006-3223
-
Container-title:Biological Psychiatry
-
language:en
-
Short-container-title:Biological Psychiatry
Author:
Holze Friederike,
Gasser Peter,
Müller Felix,
Dolder Patrick C.,
Liechti Matthias E.ORCID
Subject
Biological Psychiatry
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation;European Journal of Pharmacology;2024-03
2. Synthetic surprise as the foundation of the psychedelic experience;Neuroscience & Biobehavioral Reviews;2024-02
3. Serotonergic Psychedelics – a Comparative review Comparing the Efficacy, Safety, Pharmacokinetics and Binding Profile of Serotonergic Psychedelics;Biological Psychiatry: Cognitive Neuroscience and Neuroimaging;2024-02
4. Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study;Journal of Psychopharmacology;2024-01-27
5. Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial;BMC Psychiatry;2024-01-26